The procedure is performed by an experienced retinal surgeon, with second sight technicians available for your support. It has been implanted into more than 90 patients worldwide. The system has been approved in europe and in the us. It captures images in real time and sends images to a microchip. Fda recommends approval for second sights argus ii. Mar 06, 2018 argus ii covered in majority of medicare administrative contractor jurisdictions across 31 statessylmar, calif. Fda recommends approval for second sights argus ii retinal. Argus ii retinal prosthesis system dry amd feasibility. Second sight argus ii retinal prosthesis system english. Second sight argus ii retinal prosthesis system artificial retina bionic eye. Stem cell therapy gives her a second chance at sight trojan. The implants maker, second sight, estimates that about 350 people in the world now use it. The argus ii version of the system was approved for marketing in the european.
In late 2016, second sight medical products sylmar, ca released 5 years worth of results of their clinical study of the effects of. A grid of photodiodes, implanted in the eye of a person with macular. Second sight argus ii eye prosthesis brings central vision to. Uk government announces funding for second sights argus ii. Second sight medical products announced that the argus ii retinal prosthesis system has been implanted in the first patient in asia through an exclusive distribution partnership with orient europharma co. Argus ii retinal prosthesis system dry amd feasibility study. Fda approves first retinal implant scientific american. Stem cell therapy gives her a second chance at sight. Eyes, a developer, manufacturer and marketer of implantable visual prosthetics for blind patients suffering from retinitis pigmentosa rp, announced it has received a positive recommendation from advisors to the u. Jun 27, 2016 the second sight argus ii retinal prosthesis system is the first approved device in the entire world to help patients who are experiencing blindness, depending on the circumstances. The argus ii retinal prosthesis system second sight medical products. Argus ii offers a relatively crude form of artificial vision.
First amd patient receives argus ii bionic retinafoundation. Oct 07, 2012 second sight en 2012 argus ii retinal prosthesis system artificial retina bionic eye. Governments health care funding authority for specialized services in england. Jan 22, 2014 second sight s argus ii retinal prosthesis system is approved as a humanitarian use device to treat adults ages 25 or older with advanced retinitis pigmentosa, an inherited condition that can. The argus ii retinal prosthesis bionic eye receives. Eyes second sight or the company, a developer, manufacturer and marketer of implantable visual prosthetics intended to create an artificial form of useful vision. Oct 07, 2012 second sight argus ii retinal prosthesis system artificial retina bionic eye. Optimal placement of the argus ii retinal prosthesis system second sight medical products, sylmar, ca is critical. Retinal implants implant uses electrical stimulation to bypass defective photoreceptors and stimulate remaining viable retinal cells.
Correct coding argus ii retinal prosthesis system noridian. Second sight announces record number of argus ii retinal. Second sight, effectively the first company to bring rudimentary sight back to blind patients with certain underlying eye conditions retinitis pigmentosa and outer retinal degeneration, is now. Argus ii retinal prosthesis approved in canada american. Palankers team has designed a retinal implant of about 400. The implant is an epiretinal prosthesis surgically implanted in and on the eye that includes an antenna, an electronics case, and an electrode array. Retinal implant for macular degeneration tested in first. Right now, approval is valid for the united states and the european economic area.
Information and power are transmitted to the electronics case via the antenna. The argus ii retinal prosthesis system is an fda approved visual prosthesis. A cartoon of an implanted argus ii epiretinal implant, developed by second sight. Second sight is currently conducting a trial to test the safety and utility of the argus ii in individuals.
The device is intended for patients 25 years or older who have severe to profound retinitis pigmentosa, bare or no light perception, evidence. Second sight announces expansion of medicare coverage for. Food and drug administration fda ophthalmic devices advisory panel unanimously voted 190 that the probable benefit of the argus ii retinal prosthesis system. Second sight launches argus retinal prosthesis in iran. These implantable devices are planned to supplant photo transduction within the eyes of persons with major retinal illnesses such as agerelated macular degeneration or retinitis pigmentosa. Second sight en 2012 argus ii retinal prosthesis system artificial retina bionic eye. The argus ii is made by second sight medical products, a u. Artificial retina implant offers second sight helix. Second sight argus ii eye prosthesis brings central vision to amd patient. This implant has the potential to stop the progression of the disease or even improve patients vision. Second sights argus ii retinal prosthesis system is approved as a humanitarian use device to treat adults ages 25 or older with advanced retinitis pigmentosa, an inherited condition that can. Rp is a leading cause of blindness resulting in incurable visual impairment and drastic reduction in the quality of life of the patients.
Jul 22, 2015 the argus ii retinal prosthesis system, built by secondsight, is designed to stimulate a patients remaining retinal cells,allowing them to obtain useful visual information. The fda approved device, produced by the californiabased company second sight, allows patients with little or no vision to see movement and shapes using an implant. Once implanted, the argus ii implant sits in and around the back of the eye and is not visible to others. Artificial retina implant offers second sight helix magazine. Second sight argus ii retinal prosthesis system device. About second sight second sight medical products inc. Of the approximately 20 research groups that are actively developing visual prostheses, ssmp has the longest track record.
The costeffectiveness of the argus ii retinal prosthesis in. Second sight announces latest expansion of medicare. The argus ii system is the second generation of retinal prosthesis developed by second sight. This device is approved for use in patients blind from photoreceptor loss and has been shown to improve a patients ability to perceive images, and to help in tasks involving.
Fda approves first retinal implant scientific american blog. Implanting the argus ii is a well established surgery, typically taking only a few hours. Second sight argus ii retinal prosthesis system francais. It is attached to the retina over the macula with a retinal tack. Just as well that second sights retinal prosthesis argus ii is already. Argus ii is the worlds first evercommercial implant. Second sight announces latest expansion of medicare coverage. Enrollment has been completed in a feasibility trial to test the safety and utility of the argus ii in individuals with dry agerelated macular degeneration. The system consists of an implant, a small portable computer and a pair of glasses with a miniature video camera. Fda panel recommends fda approval for second sights argus ii. For the first time in 40 years, he was able to see variances of light and dark, and thus, have a degree of vision that can enable him to function better on a daily basis. Intraoperative oct imaging of the argus ii retinal. Argus retinal prosthesis, also known as a bionic eye, is an electronic retinal implant manufactured by the american company second sight medical products.
Apr 14, 2014 retinitis pigmentosa rp is a hereditary genetic disease causing bilateral retinal degeneration. The alphaims system by retina implant has received regulatory approval in europe. Argus ii study group second sight medical products, inc. The food and drug administration fda thursday approved the first retinal implant for use in the united states. These patients gradually lose their night and peripheral vision which progressively gets worse so that their color and central vision eventually become affected. Mar 15, 20 different groups approach this in different ways. Second sights argus ii retinal prosthesis implanted in first. Four more patients with dry macular degeneration will receive a retinal implant called the argus ii retinal prosthesis. The argus implant directly stimulates the ganglion cells. Second sight implants orion prosthesis in first human patient. Fda approval for marketing under this indication was granted on february, 20. Enrollment has been completed in a trial to test the safety and utility of the argus ii in individuals with dry.
Argus ii user ray flynn, who has agerelated macular degeneration. Costeffectiveness of the argus ii retinal prosthesis. Implanted 30 argus ii retinal prosthesis systems worldwide during the. This economic evaluation concludes that argus ii retinal prosthesis system is a costeffective device to treat rp patients. Feb 15, 20 fda approves second sight s argus ii retinal prosthesis system published.
Eyes second sight or the company, a developer, manufacturer and marketer of implantable visual prosthetics intended to create an artificial form of useful vision for blind individuals, today. Agerelated macular degeneration patient receives bionic. Fda panel recommends fda approval for second sights. Second sight is currently conducting a trial to test the safety and utility of. To date, argus ii artificial retina is implanted in four patients in iran.
For example, last year a 73yearold man receiving a second sight argus ii implant at moorfields eye hospital in london was able to see again for. Second sight announces first agerelated macular degeneration. From the electronic case, electric impulses are sent to various electrodes on the array, depending upon the information received. The latest research, entitled longterm results from. Implant our implant is an epiretinal that is, the retinal surface is the site of stimulation prosthesis that. Proving its safety in humans is the first step in accomplishing that goal. Argus ii is the worlds first evercommercial implant intended to. Eyes said today it launched its argus ii retinal prosthesis system in iran, facilitated through its exclusive distribution partner arshia gostar darman.
New clinical trial results from the argus ii study group, an international consortium of eye and vision researchers, confirm that the argus ii, also called the bionic eye, is a safe, reliable, and effective device that significantly improves visual function and quality of life for people blinded by retinitis pigmentosa. Retinal implant market size, share, 20142026 global. Second sight argus ii eye prosthesis brings central vision. Uk government announces funding for second sights argus. Delivering functional vision, second sights argus ii retinal prosthesis is a safe, clinically. Dec 22, 2016 the publicly funded nhs system in the united kingdom will provide funding for blind patients to receive the argus ii retinal prosthesis system, according to a press release from second sight. The first recipient with dry amd, ray flynn, was fitted with the implant june 16, 2015. The argus ii retinal prosthesis system, built by secondsight, is designed to stimulate a patients remaining retinal cells,allowing them to obtain useful visual information. Evidence of active sub macular choroidal neovascularization cnv in implanted eye. Second sight, a californiabased developer of visual prosthetics and retinal implants, also said that 30 of its existing argus ii devices intended to treat retinitis pigmentosa rp and agerelated macular degeneration amd were implanted during the fourth quarter of 2017. Fda approves worlds first artificial retina the american. A digital camera thats built into a pair of glasses. Argus ii is the worlds first evercommercial implant intended to restore some vision in the. Evidence of active submacular choroidal neovascularization cnv.
A pioneering, 80yearold named ray flynn is the first amd patient to receive the argus ii, and he is already reporting that he can see things better in his garden. Second sight medical products announced the first study that aims to establish whether blind patients with total central vision loss due to dry agerelated macular degeneration amd can benefit from an artificial retina the argus ii retinal prosthesis system, according to a company news release. Second sight has developed, and now manufactures and markets, the argus ii retinal prosthesis system. Second sights retinal prosthesis consists of five main parts. The argus ii system takes the place of these photoreceptors. Fda approves second sights argus ii retinal prosthesis system published. Agerelated macular degeneration patient receives bionic eye. The argus ii retinal prosthesis second sight medical products, inc. New technologies promise sharper artificial vision for blind people. Jun 25, 2015 new clinical trial results from the argus ii study group, an international consortium of eye and vision researchers, confirm that the argus ii, also called the bionic eye, is a safe, reliable, and effective device that significantly improves visual function and quality of life for people blinded by retinitis pigmentosa. Dec 22, 2016 second sight developed and manufactures the argus ii retinal prosthesis system.
The argus ii retinal prosthesis system eyecare tomorrow. A retinal implant is also termed as the argus ii retinal prosthesis system or bionic eye. The fdas green light for second sights argus ii retinal prosthesis system. Second sight argus ii retinal prosthesis system to be.
Second sight has developed and manufactures the argus ii retinal prosthesis system. The argus ii implant, developed by second sight medical products ssmp, sylmar, ca, usa, targets the retina and features 60 electrodes that electrically stimulate the surviving retinal neurons. Argus ii retinal implant bionic eye retinal prosthesis system 2. Aug 28, 2014 ocular diseases or conditions that could prevent the argus ii implant from working e. The costeffectiveness of the argus ii retinal prosthesis. Food and drug administration fda ophthalmic devices advisory panel unanimously voted 190 that the probable benefit of the argus ii. Health canada has approved the argus ii retinal prosthesis system second sight medical products, the first retinal implant for adults with advanced retinitis pigmentosa. On august 15, 20, second sight medical products, inc. Argus ii covered in majority of medicare administrative contractor jurisdictions across 31 statessylmar, calif. The argus ii retinal prosthesis system second sight medical products, inc.
Eyes second sight or the company, a developer, manufacturer and marketer of implantable visual prosthetics that are intended to provide some useful vision to blind patients, today announced that the argus ii retinal prosthesis system argus ii has been implanted in the first patient in asia through an. Apr, 2017 second sight has developed and manufactures the argus ii retinal prosthesis system. Second sights implantable retinal prosthesis the world. The argus ii has been implanted in more than 100 patients who have end stage retinitis pigmentosa, a retinal condition that is somewhat the opposite of macular degeneration. Retinitis pigmentosa rp is a hereditary genetic disease causing bilateral retinal degeneration. Governments health care funding authority for specialized services in. Sylmar, ca manufactures and markets the argus ii, a device some refer to as the bionic eye or artificial retina. The functional performance of the argus ii retinal prosthesis. Second sights argus ii retinal prosthesis implanted in. The publicly funded nhs system in the united kingdom will provide funding for blind patients to receive the argus ii retinal prosthesis system. It combines a miniature eye implant with a patientworn camera and. The retinal implant consists of a thin synthetic substrate coated with human embryonic stem cellderived retinal pigment epithelium cells. Ocular diseases or conditions that could prevent the argus ii implant from working e. In 20, the fda approved the second generation argus ii for use in those with blindness caused by severe to profound cases of retinitis pigmentosa.
Use of companys argus ii implant is also growing, with clinical study of retinitis. Uk government to fund second sights argus ii retinal. Second sight medical products announced the first study that aims to establish whether blind patients with total central vision loss due to dry agerelated macular degeneration amd can benefit from an artificial retina the argus ii retinal prosthesis system, according to a. Jul 22, 2015 second sight has developed, and manufactures, the argus ii retinal prosthesis intended to provide some useful vision to individuals with outerretinal degenerations such as retinitis pigmentosa. Second sight s argus ii retinal prosthesis system is intended to provide electrical stimulation of the retina to induce visual perception in blind individuals. Food and drug administration today approved the argus ii retinal prosthesis system, the first implanted device to treat adult patients with advanced retinitis pigmentosa rp. Apr 06, 2018 this implant has the potential to stop the progression of the disease or even improve patients vision. In late 2016, second sight medical products sylmar, ca released 5 years worth of results of their clinical study of the effects of the argus ii retinal prosthesis system for.
977 804 589 1185 461 85 215 1354 852 504 257 1452 1133 715 395 763 893 1520 22 587 496 1100 765 48 607 457 787 529 143 742 823 837